These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19671806)

  • 41. Pretreatment serum levels of anti-cyclic citrullinated peptide antibodies are associated with the response to methotrexate in recent-onset arthritis.
    Visser K; Verpoort KN; van Dongen H; van der Kooij SM; Allaart CF; Toes RE; Huizinga TW; van der Helm-van Mil AH
    Ann Rheum Dis; 2008 Aug; 67(8):1194-5. PubMed ID: 18621971
    [No Abstract]   [Full Text] [Related]  

  • 42. Optimization of high-throughput autoantibody profiling for the discovery of novel antigenic targets in rheumatoid arthritis.
    Somers K; Stinissen P; Somers V
    Ann N Y Acad Sci; 2009 Sep; 1173():92-102. PubMed ID: 19758137
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anticyclic citrullinated peptide antibody-negative rheumatoid arthritis: clues to disease pathogenesis.
    Crow MK
    Curr Rheumatol Rep; 2008 Jul; 10(3):165-7. PubMed ID: 18638423
    [No Abstract]   [Full Text] [Related]  

  • 44. Association of severe inflammatory polyarthritis in primary Sjögren's syndrome: clinical, serologic, and HLA analysis.
    Mohammed K; Pope J; Le Riche N; Brintnell W; Cairns E; Coles R; Bell DA
    J Rheumatol; 2009 Sep; 36(9):1937-42. PubMed ID: 19487261
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-citrullinated protein antibodies in rheumatoid arthritis: a bridge between genetic predisposition and autoimmunity.
    Kim HR
    Korean J Intern Med; 2013 Jan; 28(1):25-8. PubMed ID: 23345993
    [No Abstract]   [Full Text] [Related]  

  • 46. Shared epitope and anti-cyclic citrullinated peptide antibodies: relationship with age at onset and duration of disease in rheumatoid arthritis.
    Varadé J; Loza-Santamaría E; Fernández-Arquero M; Lamas JR; de Los Angeles Figueredo M; Jover JA; de la Concha EG; Rodríguez L; Urcelay E; Fernández-Gutiérrez B; Martínez-Doncel A
    J Rheumatol; 2009 May; 36(5):1085-6. PubMed ID: 19435975
    [No Abstract]   [Full Text] [Related]  

  • 47. Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways.
    Trouw LA; Haisma EM; Levarht EW; van der Woude D; Ioan-Facsinay A; Daha MR; Huizinga TW; Toes RE
    Arthritis Rheum; 2009 Jul; 60(7):1923-31. PubMed ID: 19565507
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Very early 'Rheumatoid' arthritis cohorts: limited by selection.
    Inanc M
    Rheumatology (Oxford); 2007 Feb; 46(2):185-7. PubMed ID: 17043049
    [No Abstract]   [Full Text] [Related]  

  • 49. Acute onset of polyarthralgia and high anti-cyclic citrullinated peptide antibodies in a case of idiopathic granulomatous hypophysitis.
    Babey M; Aeberli D; Vajtai I; Sahli R
    J Rheumatol; 2009 Jan; 36(1):204-7. PubMed ID: 19208539
    [No Abstract]   [Full Text] [Related]  

  • 50. [Rheumatoid arthritis nd citrullinated antigens].
    Yamamoto K; Yamada R
    Nihon Naika Gakkai Zasshi; 2005 May; 94(5):984-9. PubMed ID: 15926472
    [No Abstract]   [Full Text] [Related]  

  • 51. Comparison of the anti-cyclic citrullinated peptide and rheumatoid factor in rheumatoid arthritis at an arthritis center.
    Attar SM; Bunting PS; Smith CD; Karsh J
    Saudi Med J; 2009 Mar; 30(3):446-7. PubMed ID: 19271083
    [No Abstract]   [Full Text] [Related]  

  • 52. [Anti-citrullinated peptide antibodies: novel markers for rheumatoid polyarthritis].
    Yalaoui S
    Arch Inst Pasteur Tunis; 2006; 83(1-4):13-7. PubMed ID: 19388592
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Autoantibodies to cyclic citrullinated peptide in a PMR inception cohort from The PMR Outcomes Study.
    Dasgupta B; Hutchings A; Hollywood J; Nutter L
    Ann Rheum Dis; 2008 Jun; 67(6):903-4. PubMed ID: 18474666
    [No Abstract]   [Full Text] [Related]  

  • 54. Association of polymorphisms in interleukin-10 gene promoter with autoantibody production in patients with rheumatoid arthritis.
    Nemec P; Goldbergova MP; Gatterova J; Vasku A; Soucek M
    Ann N Y Acad Sci; 2009 Sep; 1173():501-8. PubMed ID: 19758192
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Not steroids again.
    Russell A
    J Rheumatol; 2007 Sep; 34(9):1942; author reply 1942-3. PubMed ID: 17787054
    [No Abstract]   [Full Text] [Related]  

  • 56. [Significance of antibodies to cyclic citrullinized peptide in diagnostics of rheumatoid arthritis].
    Cheremis NA; Nasonov EL
    Klin Med (Mosk); 2005; 83(8):48-53. PubMed ID: 16218364
    [No Abstract]   [Full Text] [Related]  

  • 57. "ACPA" in Rheumatoid Arthritis: From Population-based Data to Personalized Medicine.
    Ménard HA
    J Rheumatol; 2015 May; 42(5):733-5. PubMed ID: 25934875
    [No Abstract]   [Full Text] [Related]  

  • 58. Very low prevalence of anti-CCP antibodies in rheumatoid factor-negative psoriatic polyarthritis.
    Pasquetti P; Morozzi G; Galeazzi M
    Rheumatology (Oxford); 2009 Mar; 48(3):315-6. PubMed ID: 19109316
    [No Abstract]   [Full Text] [Related]  

  • 59. Organ-specific autoantibodies but not anti-cyclic citrullinated peptides are a feature of autoimmunity in Down's syndrome.
    Fisher BA; Charles P; Lundberg K; Gillespie KM; Newton RW; Venables PJ
    Ann Rheum Dis; 2010 May; 69(5):939-40. PubMed ID: 20388737
    [No Abstract]   [Full Text] [Related]  

  • 60. Definition of clinical differences.
    de Vet HC; Beckerman H; Terwee CB; Terluin B; Bouter LM
    J Rheumatol; 2006 Feb; 33(2):434; author reply 435. PubMed ID: 16465677
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.